Log In
BCIQ
Print this Print this
 

MAT-302

  Manage Alerts
Collapse Summary General Information
Company MABLife S.A.S
DescriptionAntibody against CD160 receptor
Molecular Target CD160
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/02/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today